Johnson & Johnson Will Pay $70 Million Over Bribery Claims

Johnson & Johnson, the world’s second-biggest seller of medical products, will pay $70 million after admitting that the company bribed doctors in Europe and paid kickbacks in Iraq to win contracts and sell drugs and artificial joints.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.